Search

Author/Creator Vaccaro, Vanja

1. A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients. (April 2014)

Authors:
Maftouh, Mina; Avan, Amir; Funel, Niccola; Paolicchi, Elisa; Vasile, Enrico; Pacetti, Paola; Vaccaro, Vanja; Faviana, Pinuccia; Campani, Daniela; Caponi, Sara; Mambrini, Andrea; Boggi, Ugo; Cantore, Maurizio; Milella, Michele; Peters, Godefridus J; Reni, Michele; Giovannetti, Elisa
Journal:
Pharmacogenomics
Issue:
Volume 15:Number 5(2014)
Page Start:
609
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. (17th October 2018)

Authors:
Bersanelli, Melissa; Giannarelli, Diana; Castrignanò, Paola; Fornarini, Giuseppe; Panni, Stefano; Mazzoni, Francesca; Tiseo, Marcello; Rossetti, Sabrina; Gambale, Elisabetta; Rossi, Ernesto; Papa, Anselmo; Cortellini, Alessio; Lolli, Cristian; Ratta, Raffaele; Michiara, Maria; Milella, Michele; L...
Journal:
Immunotherapy
Issue:
Volume 10:Number 14(2018)
Page Start:
1229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives. Issue 6 (June 2013)

Authors:
Santoni, Matteo; De Tursi, Michele; Felici, Alessandra; Lo Re, Giovanni; Ricotta, Riccardo; Ruggeri, Enzo Maria; Sabbatini, Roberto; Santini, Daniele; Vaccaro, Vanja; Milella, Michele
Journal:
Expert review of anticancer therapy
Issue:
Volume 13:Issue 6(2013)
Page Start:
697
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives. Issue 6 (June 2013)

Authors:
Santoni, Matteo; De Tursi, Michele; Felici, Alessandra; Lo Re, Giovanni; Ricotta, Riccardo; Ruggeri, Enzo Maria; Sabbatini, Roberto; Santini, Daniele; Vaccaro, Vanja; Milella, Michele
Journal:
Expert review of anticancer therapy
Issue:
Volume 13:Issue 6(2013)
Page Start:
697
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Prognostic factors in gemcitabine–cisplatin polychemotherapy regimens in pancreatic cancer: XPD‐Lys751Gln polymorphism strikes back. Issue 4 (4th March 2013)

Authors:
Avan, Amir; Pacetti, Paola; Reni, Michele; Milella, Michele; Vasile, Enrico; Mambrini, Andrea; Vaccaro, Vanja; Caponi, Sara; Cereda, Stefano; Peters, Godefridus J.; Cantore, Maurizio; Giovannetti, Elisa
Journal:
International journal of cancer
Issue:
Volume 133:Issue 4(2013:Aug. 15)
Page Start:
1016
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. (October 2020)

Authors:
Bersanelli, Melissa; Giannarelli, Diana; De Giorgi, Ugo; Pignata, Sandro; Di Maio, Massimo; Verzoni, Elena; Clemente, Alberto; Guadalupi, Valentina; Signorelli, Diego; Tiseo, Marcello; Giusti, Raffaele; Filetti, Marco; Di Napoli, Marilena; Calvetti, Lorenzo; Cappetta, Alessandro; Ermacora, Paola;...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗